Journal of Critical Care
Volume 23, Issue 1 , Pages 50-57, March 2008

The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia

  • François Lauzier, MD, MSc

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, Université Laval, Québec City, Québec, Canada
  • ,
  • Annie Ruest, MD

      Affiliations

    • Department of Medicine, Université Laval, Québec City, Québec, Canada
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Deborah Cook, MD, MSc

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Peter Dodek, MD, MSc

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
  • ,
  • Martin Albert, MD

      Affiliations

    • Department of Medicine, Université de Montréal, Montréal, Québec, Canada
  • ,
  • Andrew F. Shorr, MD, MSc

      Affiliations

    • Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC, USA
  • ,
  • Andrew Day, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
  • ,
  • Xuran Jiang, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
  • ,
  • Daren Heyland, MD, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
    • Department of Medicine, Queen's University, Kingston, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +613 549 6666x3339; fax: +613 548 1351.
  • ,
  • for the Canadian Critical Care Trials Group

Abstract 

Purpose

The aim of the study was to assess the utility of pretest probability and modified clinical pulmonary infection score CPIS in the diagnosis of late-onset ventilator-associated pneumonia (VAP).

Materials and Methods

In 740 adults enrolled in a multicenter randomized trial, intensivists prospectively rated the pretest probability of VAP as low, moderate, or high based on their clinical judgment. The modified CPIS was calculated without considering culture results. Ventilator-associated pneumonia diagnosis was determined by 2 adjudicators using standardized definitions. We analyzed the relationship between pretest likelihood, CPIS, and VAP diagnosis.

Results

Among the 739 patients analyzed, 14.5%, 39.6%, and 45.9% had low, moderate, and high pretest probability of VAP. Patients with high pretest probability had a lower PaO2/FiO2 ratio and a larger volume of secretions. High or moderate vs low pretest probability had high sensitivity (0.88; 95% confidence interval [CI], 0.87-0.89) and positive predictive value (0.87; 95% CI, 0.86-0.88) but low specificity (0.27; 95% CI, 0.21-0.35) and negative predictive value (0.29; 95% C,: 0.22-0.37) for the diagnosis of VAP. Therefore, 71% of patients who had a low pretest probability were actually infected (1 − negative predictive value). The area under the receiver operating characteristic curve for the modified CPIS was not significant (0.47; 95% CI, 0.42-0.53), meaning that no score threshold was clinically useful.

Conclusions

Pretest probability and a modified CPIS, which excludes culture results, are of limited utility in the diagnosis of late-onset VAP.

Keywords: Clinical pulmonary infection score, Pretest probability, Pneumonia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by grants from the Canadian Institutes of Health Research and Physicians' Services Incorporated of Ontario, and by unrestricted grants from AstraZeneca and Bayer. François Lauzier and Annie Ruest are supported by a postdoctoral fellowship award from Université Laval. Annie Ruest is supported by a postdoctoral fellowship award from the Fonds de Recherche en Santé du Québec. Deborah Cook holds a Research Chair of the Canadian Institutes of Health Research.

PII: S0883-9441(08)00021-X

doi:10.1016/j.jcrc.2008.01.006

Journal of Critical Care
Volume 23, Issue 1 , Pages 50-57, March 2008